Evaluating the clinical utility of 3D genomics in uterine sarcoma

Webinar
Original webinar date Thursday, March 27, 2025

About the webinar 

This webinar will explore how 3D genomics can enhance diagnostic accuracy and uncover novel therapeutic targets in uterine sarcoma. Participants will gain insights into the advantages of 3D genomic approaches compared to traditional clinical next-generation sequencing (NGS) assays. Attendees will also learn about the implications of these advanced genomic techniques for clinical practice and patient care in gynecologic oncology.

Meet the speakers 

Anthony Schmitt, PhD
Anthony Schmitt, PhD, is the SVP of Science at Arima Genomics, where his expertise in 3D genomics has been pivotal to the company's development of Hi-C technology and its applications in genomics research. He received his PhD from the University of California, San Diego, where he developed novel methodologies for understanding gene regulation using 3D genomics approaches. Since Arima’s inception, Anthony has led the development of the core Arima Hi-C chemistry and technology platform, as well as industry partnerships and academic collaborations. 

Sarah Chiang, MD
Pathologist at Memorial Sloan Kettering Cancer Center

Sarah is a board-certified surgical pathologist with clinical expertise in gynecologic pathology. In addition to her clinical responsibilities, she maintains an active commitment to translational research in the diagnosis and pathogenesis of uterine sarcomas.